THE RAMCO CEMENT: Q1 REVENUE 22.7B RUPEES VS 20.7B (YOY); EST 22.1B

THE RAMCO CEMENT: Q1 SL NET PROFIT 318M RUPEES VS 860M (YOY); EST 250M

CARE RATINGS: Q1 EBITDA 346M RUPEES VS 277M (YOY) || Q1 EBITDA MARGIN 31.01% VS 29.52% (YOY)

CARE RATINGS: Q1 REVENUE 1.11B RUPEES VS 939M (YOY)

CARE RATINGS: Q1 CONS NET PROFIT 330M RUPEES VS 265M (YOY)

ENTERO HEALTHCARE SOLUTIONS: Q1 EBITDA 969M RUPEES VS 502M (YOY) || Q1 EBITDA MARGIN 4.99% VS 3.52% (YOY)

ENTERO HEALTHCARE SOLUTIONS: Q1 REVENUE 19.4B RUPEES VS 14B (YOY)

ENTERO HEALTHCARE SOLUTIONS: Q1 CONS NET PROFIT 382M RUPEES VS 280M (YOY)

ANUH PHARMA: Q1 EBITDA 163M RUPEES VS 103M (YOY) || Q1 EBITDA MARGIN 8.4% VS 5.52% (YOY)

ANUH PHARMA: Q1 REVENUE 1.94B RUPEES VS 1.86B (YOY)

ANUH PHARMA: Q1 SL NET PROFIT 114M RUPEES VS 83M (YOY)

JINDAL DRILLING AND INDUSTRIES: Q1 EBITDA 1.04B RUPEES VS 1.06B (YOY) || Q1 EBITDA MARGIN 37.64% VS 42.04% (YOY)

JINDAL DRILLING AND INDUSTRIES: Q1 REVENUE 2.75B RUPEES VS 2.54B (YOY)

JINDAL DRILLING AND INDUSTRIES: Q1 SL NET PROFIT 524M RUPEES VS 565M (YOY)

GREENLAM INDUSTRIES: Q1 EBITDA 797M RUPEES VS 441M (YOY) || Q1 EBITDA MARGIN 10.01% VS 6.54% (YOY)

GREENLAM INDUSTRIES: Q1 REVENUE 8B RUPEES VS 6.74B (YOY)

GREENLAM INDUSTRIES: Q1 CONS NET PROFIT 213M RUPEES VS LOSS 154M (YOY)